![Norman Anderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Norman Anderson
Algemeen Directeur bij
The Plasma Proteome Institute
Profiel
Norman Leigh Anderson was the founder of Large Scale Biology Corp.
(founded in 2001) and served as Chief Scientific Officer from 2001 to 2002.
Dr. Anderson is the founder of The Plasma Proteome Institute (founded in 2002) and holds the title of Chief Executive Officer since 2002.
Dr. Anderson is the founder of Siscapa Assay Technologies, Inc. (founded in 2011) and holds the titles of President, Chief Executive Officer & Director since 2011.
Dr. Anderson is currently Principal at Anderson Forschung Group LLC since 2011.
Formerly, Dr. Anderson was Director at Dade Behring Holdings, Inc. from 2002 to 2007.
Education includes a doctorate from the University of Cambridge and an undergraduate degree from Yale University.
Actieve functies van Norman Anderson
| Bedrijven | Functie | Begin |
|---|---|---|
The Plasma Proteome Institute
 The Plasma Proteome Institute Other Consumer ServicesConsumer Services The Plasma Proteome Institute specializes in plasma proteomics, focusing on the study and analysis of plasma proteins such as albumin, antibodies, blood clotting factors, protein hormones, cytokines, and lysosomal enzymes. The non-profit company is based in Washington, DC. The company's work involves advanced techniques including immunosubtraction and two-dimensional electrophoresis, emphasizing protein diagnostics and related research. The company was founded by Norman Leigh Anderson. Norman Leigh Anderson has been the CEO since incorporation. | Algemeen Directeur | 01-01-2002 |
Anderson Forschung Group LLC | Corporate Officer/Principal | 01-01-2002 |
Siscapa Assay Technologies, Inc.
 Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Develops immunoassays for the quantitation of protein biomarkers and targets | Oprichter | 01-01-2011 |
Eerdere bekende functies van Norman Anderson
| Bedrijven | Functie | Einde |
|---|---|---|
Dade Behring Holdings, Inc.
 Dade Behring Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures medical diagnostic equipment | Directeur/Bestuurslid | 01-01-2007 |
Large Scale Biology Corp.
 Large Scale Biology Corp. BiotechnologyHealth Technology Manufactures recombinant biologics | Oprichter | 01-01-2002 |
| LUNA INNOVATIONS INCORPORATED | Directeur/Bestuurslid | - |
Opleiding van Norman Anderson
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
15
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Large Scale Biology Corp.
Large Scale Biology Corp. BiotechnologyHealth Technology Manufactures recombinant biologics | Health Technology |
Dade Behring Holdings, Inc.
Dade Behring Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures medical diagnostic equipment | Health Technology |
Luna Innovations, Inc.
 Luna Innovations, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops and distributes fiber optic test, measurement and control products | Electronic Technology |
Siscapa Assay Technologies, Inc.
Siscapa Assay Technologies, Inc. BiotechnologyHealth Technology Develops immunoassays for the quantitation of protein biomarkers and targets | Health Technology |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Plasma Proteome Institute
The Plasma Proteome Institute Other Consumer ServicesConsumer Services The Plasma Proteome Institute specializes in plasma proteomics, focusing on the study and analysis of plasma proteins such as albumin, antibodies, blood clotting factors, protein hormones, cytokines, and lysosomal enzymes. The non-profit company is based in Washington, DC. The company's work involves advanced techniques including immunosubtraction and two-dimensional electrophoresis, emphasizing protein diagnostics and related research. The company was founded by Norman Leigh Anderson. Norman Leigh Anderson has been the CEO since incorporation. | Consumer Services |
Anderson Forschung Group LLC |
